10/20/2026
US drug firms eye ibogaine amid concerns over Gabonese supply
Interest in ibogaine for addiction treatment raises conservation concerns in Gabon.
Topic archive
19 stories
10/20/2026
Interest in ibogaine for addiction treatment raises conservation concerns in Gabon.
10/6/2026
Guidance requested for early-phase ibogaine protocols amid regulatory challenges.
10/6/2026
Ibogaine trials fast-tracked in the US amid ongoing safety debates.
10/5/2026
Partnership aims to manufacture pharmaceutical-grade ibogaine domestically.
10/1/2026
New decree aims to ensure benefit sharing from ibogaine's global trade.
9/28/2026
Texas subsidiary gains exclusive U.S. rights to PsyLabs' ibogaine
9/28/2026
Texas Ibogaine Research Corporation to lead U.S. ibogaine drug development.
9/28/2026
Texas subsidiary gains rights to ibogaine hydrochloride for drug development.
9/23/2026
Investment aims to bolster ibogaine research for opioid use disorder in Texas.
9/23/2026
Ibogaine's potential for treating addiction draws attention as regulations evolve.
9/22/2026
New extended treatment integrates ibogaine therapy with cultural exploration.
9/22/2026
Model's overdose at Malibu rehab prompts scrutiny of ibogaine use.
9/10/2026
IBEX011 stability program aims to meet growing demand for standardized ibogaine.
8/26/2026
The move promotes open science and could influence future psychedelic research.
8/19/2026
Company aligns with U.S. efforts to advance ibogaine research.
8/6/2026
Police probe follows death linked to unauthorized ibogaine use in Canada.
8/5/2026
Police charge Mississauga man after ibogaine-related death, highlighting risks.
8/5/2026
Jonathan Dickinson discusses ibogaine's potential in treating PTSD and brain injuries.
7/24/2026
White House adviser Heidi Overton shapes ibogaine policy amid internal disputes.